Ketorolac in thyroid surgery: Quantifying the risk of hematoma

Journal of Otolaryngology - Head and Neck Surgery

Volumn 40, Issue 3, 2011, Pages 196-199

  Chin, Christopher J ^a   Franklin, Jason H ^a   Turner, Benjamin ^b   Sowerby, Leigh ^a   Fung, Kevin ^a   Yoo, John H ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b WESTERN UNIVERSITY   (Canada)

Author keywords

Hematoma; Ketorolac; Surgery; Thyroid; Toradol

Indexed keywords

KETOROLAC; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; BLEEDING TIME; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEMATOMA; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE; THYROID SURGERY; THYROIDECTOMY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HEMATOMA; HUMANS; KETOROLAC; MALE; MIDDLE AGED; THYROID GLAND;

EID: 79955404815     PISSN: 19160216     EISSN: None     Source Type: Journal    
DOI: 10.2310/7070.2011.100146     Document Type: Article

References (10)

1. Gallagher JE, Blauth J, Fornadley JA. Perioperative ketorolac tromethamine and postoperative hemorrhage in cases of tonsillectomy and adenoidectomy. Laryngoscope 1995;105:606-9, doi:10.1288/00005537-199506000- 00008.
2. Pallapies D, Peskar BA, Brune K, et al. Effects on platelet functions and pharmacokinetics of azopropazone and ketorolac tromethamine given as single parenteral doses. Br J Clin Pharmacol 1994;37: 335-9. (Pubitemid 24204596)
3. Bailey R, Sinha C, Burgess L. Ketorolac tromethamine and hemorrhage in tonsillectomy: a prospective, randomized, double-blind study. Laryngoscope 1997;107:166-9, doi:10.1097/00005537-199702000-00006. (Pubitemid 27076674)
4. Judkins JH, Dray TG, Hubbell RN. Intraoperative ketorolac and posttonsillectomy bleeding. Arch Otolaryngol Head Neck Surg 1996;122:937-40. (Pubitemid 26304229)
5. Abbas G, Dubner S, Heller KS. Re-operation for bleeding after thyroidectomy and parathyroidectomy. Head Neck 2001;23:544-6, doi:10.1002/hed.1076. (Pubitemid 32565527)
6. Serpell JW, Phan D. Safety of total thyroidectomy. Aust N Z J Surg 2007;77:15-9, doi:10.1111/j.1445-2197.2006.03897.x. (Pubitemid 46145615)
7. Gaujoux S, Leenhardt L, Trésallet C, et al. Extensive thyroidectomy in Graves' disease. J Am Coll Surg 2006;202:868-73, doi:10.1016/j.jamcollsurg.2006.02.031. (Pubitemid 43776454)
8. Bergamaschi R, Becourarn G, Ronceray J, Arnaud J-P. Morbidity of thyroid surgery. Am J Surg 1998;176:71-5, doi:10.1016/S0002-9610(98)00099-3. (Pubitemid 28340962)
9. Gillies GW, Kenny GN, Bullingham RE, McArdle CS. The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia 1987;42:727-31, doi:10.1111/j.1365-2044.1987.tb05317.x.
10. Sharma S, Chang DW, Koutz C, et al. Incidence of hematoma associated with ketorolac after TRAM flap breast reconstruction. Plast Reconstr Surg 2001;107:352-5, doi:10.1097/00006534-200108000-00011. (Pubitemid 32125276)